HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dihydropyrimidine dehydrogenase deficiency in an Indian population.

AbstractBACKGROUND:
Dihydropyrimidine dehydrogenase (DPD) deficiency is prevalent in 3-5% of the Caucasian population; however, the frequency of this pharmacogenetic syndrome in the Indian population and other racial and ethnic groups remains to be elucidated.
PATIENTS AND METHODS:
We describe an Indian patient who presented to clinic for the treatment of gastric adenocarcinoma with 5-flurouracil (5-FU) therapy who subsequently was diagnosed with DPD deficiency by using the peripheral blood mononuclear cell (PBMC) DPD radioassay. This observation prompted us to examine the data generated from healthy (cancer-free) Indian subjects who were enrolled in a large population study to determine the sensitivity and specificity of the uracil breath test (UraBT) in the detection of DPD deficiency. Thirteen Indian subjects performed the UraBT. UraBT results were confirmed by PBMC DPD radioassay.
RESULTS:
The Indian cancer patient demonstrated reduced DPD activity (0.11 nmol/min/mg protein) and severe 5-FU toxicities commonly associated with DPD deficiency. Of the 13 Indian subjects [ten men and three women; mean age, 26 years (range: 21-31 years)] enrolled in the UraBT, 12 Indian subjects demonstrated UraBT breath profiles and PBMC DPD activity within the normal range; one Indian subject demonstrated a reduced breath profile and partial DPD deficiency.
CONCLUSIONS:
DPD deficiency is a pharmacogenetic syndrome which is also present in the Indian population. If undiagnosed, the DPD deficiency can lead to death. Future epidemiological studies would be helpful to determine the prevalence of DPD deficiency among racial and ethnic groups, allowing for the optimization of 5-FU chemotherapy.
AuthorsMuhammad Wasif Saif, Lori Mattison, Tom Carollo, Hany Ezzeldin, Robert B Diasio
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 58 Issue 3 Pg. 396-401 (Sep 2006) ISSN: 0344-5704 [Print] Germany
PMID16421754 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Dihydrouracil Dehydrogenase (NADP)
Topics
  • Adult
  • Breath Tests
  • Chromatography, High Pressure Liquid
  • Dihydropyrimidine Dehydrogenase Deficiency
  • Dihydrouracil Dehydrogenase (NADP) (genetics)
  • Fatal Outcome
  • Female
  • Genotype
  • Humans
  • India
  • Leukocytes, Mononuclear (enzymology)
  • Male
  • Metabolic Diseases (complications, diagnosis, enzymology)
  • Middle Aged
  • Radioligand Assay
  • Sensitivity and Specificity
  • Stomach Neoplasms (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: